Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
07/2001
07/03/2001US6255338 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors
07/03/2001US6255309 Plants
07/03/2001US6255305 Substituted triazolo-pyridazine derivatives as ligands for GABA receptors
07/03/2001US6255087 For example, enantioselective reduction of 7-(1-oxoethyl)-1,2,4-triazolo(1,5-a)pyrimidine to 7-(1-hydroxyethyl)-1,2,4-triazolo(1,5-a)pyrimidine with microogranisms in the presence of glucose as carbon source
07/03/2001CA2206327C Oxytitanium phthalocyanine crystal
06/2001
06/28/2001WO2001046200A1 Novel piperidine and piperazine derivatives
06/28/2001WO2001046197A1 PEPTIDE β-TURN MIMETIC COMPOUNDS AND PROCESSES FOR MAKING THEM
06/28/2001WO2001046196A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
06/28/2001WO2001046195A1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
06/28/2001WO2001046194A2 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives
06/28/2001WO2001046189A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
06/28/2001WO2000077010A3 Substituted heterocycle fused gamma-carbolines
06/28/2001WO2000075144A3 Peroxynitrite decomposition catalysts and methods of use thereof
06/28/2001WO1999063937A9 Multivalent macrolide antibiotics
06/28/2001DE19962928A1 New aminosulfonyl-substituted 3H-imidazo (1,5-a) (1,3,5) triazin-4-one derivatives, are phosphodiesterase inhibitors, useful for treating cardiovascular, cerebrovascular or urogenital disorders
06/28/2001DE19962927A1 New aminosulfonyl-substituted (1,2,4)-triazolo (3,4-f) (1,2,4) triazin-8(7H)-one derivatives, are phosphodiesterase inhibitors useful for treating cardiovascular, cerebrovascular or urogenital disorders
06/28/2001DE19962455A1 Preparation of pure triethylenediamine solution and crystals, useful as catalyst for polyurethane foam production, comprises vaporization, passing vapor into liquid solvent and crystallization from solution
06/28/2001CA2395569A1 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives
06/28/2001CA2395520A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
06/28/2001CA2394095A1 Novel piperidine and piperazine derivatives
06/28/2001CA2393759A1 Peptide .beta.-turn mimetic compounds and processes for making them
06/27/2001EP1110963A2 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
06/27/2001EP1110952A1 Carboxylic acid derivates, their preparation and use
06/27/2001EP1109816A1 Vinyl substituted cyclic products of the ene-yne reaction
06/27/2001EP1109814A1 5-heterocyclyl pyrazolo 4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
06/27/2001EP1109813A1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
06/27/2001EP1109812A2 Pyrrolobenzodiazepines
06/27/2001EP1109811A2 Pyrrolobenzodiazepines
06/27/2001EP1109785A2 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
06/27/2001EP1109543A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
06/27/2001EP1109542A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
06/27/2001EP0862564A4 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases
06/27/2001EP0733046B1 benzoyl guanidines, their production and their use in medicaments
06/27/2001CN1301266A Triazolopurine derivatives, medicinal composition containing the derivatives, adenosine A3 receptor compatibilizing agent, and asthmatic remedy
06/27/2001CN1301262A Novel herbicides
06/27/2001CN1067686C Fused polycyclic heterocycle derivatives
06/27/2001CN1067683C Substituted morpholine derivatives and their use as therapeutic agents
06/26/2001US6252066 Quarternary polycyclic polyammonium salts and process for their preparation
06/26/2001US6251916 For therapy of pain
06/26/2001US6251911 Pyrimidine derivatives and processes for the preparation thereof
06/26/2001US6251910 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists
06/26/2001US6251904 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
06/26/2001US6251903 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist
06/26/2001US6251902 Dipeptide derivatives as growth hormone secretagogues
06/26/2001US6251894 1-(1,2-disubstituted piperidinyl)-4 (fused imidazole)-piperidine derivatives
06/26/2001US6251893 Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
06/26/2001US6251854 N-methyl-d-aspartate receptor channel blockers and method for identifying such
06/26/2001US6251831 Herbicidal sulphonylamino(thio)carbonyl compounds
06/26/2001US6251830 Pesticides and herbicides
06/26/2001US6251829 Preemergent and postemergent herbicides
06/26/2001US6251367 Porphyrin complexes with metals
06/26/2001CA1341261C Process for the synthesis of 3',4'-anhydrovinblastine, vinblastine and vincristine
06/21/2001WO2001044260A2 Novel purines
06/21/2001WO2001044259A1 Purine derivatives
06/21/2001WO2001044258A1 Novel heterocycles
06/21/2001WO2001044257A1 Proton pump inhibitors
06/21/2001WO2001044251A1 Process for production of optically active pyrroloazepine derivatives
06/21/2001WO2001044250A1 SUBSTITUTED 1,2,3-TRIAZOLO[1,5-a]QUINAZOLINES FOR ENHANCING COGNITION
06/21/2001WO2001044249A1 Triazolo-pyrimidine derivatives as ligands for gaba receptors
06/21/2001WO2001044247A2 Agents and methods for the treatment of proliferative diseases
06/21/2001WO2001044243A2 Novel heteroaryl-diazabicycloalkanes
06/21/2001WO2001044239A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
06/21/2001WO2001043741A1 Cytotoxic n-unsubstituted indoles and cyclopent(b)indoles and method of making and using same
06/21/2001WO2001016136A3 Tricyclic inhibitors of poly(adp-ribose) polymerases
06/21/2001CA2395088A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
06/21/2001CA2394654A1 Proton pump inhibitors
06/21/2001CA2394650A1 Novel heterocycles
06/21/2001CA2394646A1 Novel purines
06/21/2001CA2394573A1 Purine derivatives
06/21/2001CA2392955A1 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
06/21/2001CA2392953A1 Triazolo-pyrimidine derivatives as ligands for gaba receptors
06/21/2001CA2363094A1 Method for the preparation of optically active pyrroloazepine derivatives
06/20/2001EP1108000A1 Process for the preparation of substituted amido phthalocyanine derivatives and substituted amido phthalocyanine derivatives
06/20/2001EP1107971A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
06/20/2001EP1107970A2 Collections of compounds
06/20/2001EP1107969A2 Collections of compounds
06/20/2001EP1107968A2 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
06/20/2001EP1107967A2 Triazolopyridazine derivatives for treating anxiety and enhancing cognition
06/20/2001EP1107959A2 Quinazoline derivatives as medicaments
06/20/2001EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
06/20/2001EP0890176B1 Proton conductor in liquid form
06/20/2001EP0714394B1 Antipsychotic method with thiadiazole and oxadiazole derivatives
06/20/2001CN1300289A Novel cephalotaxane derivatives and process for their preparation
06/20/2001CN1067396C Processes of producing N,N' diffluorodiazoniabicyclo-alkane salts
06/20/2001CN1067395C Process for preparing diketopyrrolpyrrde derivatives
06/20/2001CN1067394C Process for preparation of enantiomerically pure cycloalkano-indol-and azaindol-and pyrimido [1,2a] indol-carbocylic acids and their activated derivatives
06/20/2001CN1067393C Novel pyrimido [1,2-alpha] indoles
06/20/2001CN1067386C 5-heteroarylindole derivatives as benzodiazepine receptor site agnoists and analagonists
06/19/2001USRE37234 Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
06/19/2001US6248884 Particularly well suited for use in automated fluorescence-based dna sequencing systems using an excitation light source having a wavelength greater than about 630 nm, e.g., a helium-neon gas laser or a solid state diode laser.
06/19/2001US6248755 Antiinflammatory agents; antiallergens; autoimmune diseases
06/19/2001US6248745 Mixture comprising a cyclooxygenase-2 (cox-2) inhibitor and a 1,2-dihydro-4-aminoquinazoline derivative inhibitor of induced nitric oxide synthase (inos); non-steroidal antiinflammatory agents
06/19/2001US6248742 Administering dna protective agent/anticarcinogenic agent for treatment of oxidative stress manifested in infections and inflammations
06/19/2001US6248740 Condensed pyridazine derivatives, their production and use
06/19/2001US6248137 Compositions for dyeing keratinous fibres, containing 3-aminopyrazolo [1,5-a]pyrimidines, method of dyeing and novel 3-aminopyrazolo [1,5-a]pyrimidines
06/19/2001CA2136447C Selective cell inactivation in blood
06/19/2001CA2095444C Fused pyrazine derivatives
06/14/2001WO2001042391A2 A new family of conducting liquid crystals
06/14/2001WO2001042368A1 Substituted phthalocyanines and their precursors
06/14/2001WO2001042247A1 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same